Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024

Sarah K Nørgaard,Jens Nielsen,Anne Christine Nordholm,Lukas Richter,Alena Chalupka,Natalia Bustos Sierra,Toon Braeye,Maria Athanasiadou,Theodore Lytras,Gleb Denissov,Oskari Luomala,Anne Fouillet,Isabelle Pontais,Matthias An der Heiden,Benedikt Zacher,Alina Weigel,Ivo Foppa,Kassiani Gkolfinopoulou,Ioannis Panagoulias,Anna Paldy,Tibor Malnasi,Lisa Domegan,Eva Kelly,Naama Rotem,Oksana Rakhlin,Francesca K de'Donato,Chiara Di Blasi,Patrick Hoffmann,Telma Velez,Kathleen England,Neville Calleja,Liselotte van Asten,Femke Jongenotter,Ana Paula Rodrigues,Susana Silva,Petra Klepac,Diana Gomez-Barroso,Inmaculada Leon Gomez,Ilias Galanis,Ahmed Farah,Rolf Weitkunat,Katarina Fehst,Nick Andrews,Tom Clare,Declan T Bradley,Mark G O'Doherty,Naoma William,Mark Hamilton,Bolette Søborg,Tyra G Krause,Nick Bundle,Lasse S Vestergaard
DOI: https://doi.org/10.2807/1560-7917.ES.2024.29.15.2400178
Abstract:Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023-6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI: 91.7-98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season.
What problem does this paper attempt to address?